No­var­tis to make com­mer­cial Carvyk­ti; Re­ci­pharm di­vests sev­en fa­cil­i­ties; Lil­ly’s Zep­bound in short­age 

Wel­come to End­points News’ man­u­fac­tur­ing briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more.

No­var­tis ex­tend­ed its deal with John­son …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER